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crest with reduced numbers of neural crest derived cells seen in the
facial primordia. Using positional mapping we identified Pak1ip1 as
the mutated gene in mray mice. Through previous work in yeast
Pak1ip1 has been characterized as a negative regulator of Pak1
activity linking it to processes of cytoskeletal rearrangement, cell
polarity and morphogenetic movements. Expression analysis shows
that Pak1ip1 and Pak1 are widely expressed during embryonic
development, underlining the idea that they are fundamental
regulators of cellular morphology during development.
doi:10.1016/j.ydbio.2009.05.407
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The forebrain is the largest portion of the human brain and is
responsible for many higher order cognitive functions including
reasoning and memory. To identify genes required for mammalian
forebrain development, we have conducted an ENU mutagenesis
screen in the mouse. Using this unbiased, forward genetic approach,
we have ascertained seven mutations affecting CNS development and
have thus far identified four by positional cloning. The most
remarkable phenotype uncovered to date is the rudolph mutation
with severe developmental defects in both the CNS and appendicular
skeleton (smaller long bones). The organization of the neocortex is
profoundly disrupted and contains clustered cell bodies, which
appear to be neurogenic foci. The causal gene is known to play a
role in cholesterol biosynthesis, which is notable given the recent
implication of a role for oxysterols in mediating intracellular
components of Hedgehog signaling. We see decreased induction of
known Sonic hedgehog (Shh) target genes in the cortex, retina and
skeleton. In vitro, this mutation results in decreased cellular response
to Shh, revealing a requirement for embryonic cholesterol metabo-
lism in both CNS development and normal Shh signaling. Other
mutations in our screen show phenotypes such as cortical hypocel-
lularity, hydrocephaly, anterior encephalocele, and craniorachischisis.
Thus, we have demonstrated the utility of a forward genetic approach
in studying neurodevelopment. We will also describe our efforts to
enrich our screen for mutations affecting forebrain development.
doi:10.1016/j.ydbio.2009.05.408
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The sensory cranial ganglia are derived from late migrating neural
crest cells and regions of ectodermal thickening called placodes.
Fibroblast growth factors (Fgfs) have been implicated in olfactory,
epibranchial and otic placode development, as well as neural crest
migration. The Sprouty (Spry) gene family encodes feedback antago-
nists of Fgf signalling. BetweenE8.5 andE9.5 Spry1and2 are transiently
expressed in the region of the developing epibranchial placodes and
latemigrating neural crest cells. Embryos lacking both Spry1 and Spry2
exhibit abnormal morphology in the proximal and/or distal regions of
the cranial nerves V, VII/VIII, IX and X. Aberrant Sox 10 expression at
E9E9.5 implies that Spry is required for the development of late
migrating neural crest cells. However, the sensory cranial ganglia in the
neural crest-specific conditional Spry1;2 double knockout (Wnt1cre;
Spry1flox/−;2flox/−) are normal, suggesting that Spry expressionwithin
neural crest cells is not required for normal development. Alternatively
Spry may have a role in placodal formation and differentiation as the
expression of placodal and early neuronal markers is altered at E9.5 in
Spry1; 2 double knockouts. Together this data indicates that Spry gene
function is required for the development of the sensory cranial ganglia.
doi:10.1016/j.ydbio.2009.05.409
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Folate supplementation has been used to prevent neural tube
defects (NTDs) during pregnancy formany years. NTD andNTD related
defects span a wide range from minor spinal malformations through
occulta (mild), to anencephaly (severe). Although folate appears to
prevent most NTDs some still occur whether from genetic abnormal-
ities or for environmental factors. For our research group two
important questions are is there one level of folate that should be
sustained during pregnancy or should the recommended folate levels
be stage specific and whether excess levels folate can alter embryonic
development?Timedpregnant ICRmicewere treatedon the eveningof
E11with sterile saline,1XFA(12mg/kg folinic acid)or4XFA(48mg/kg
folinic acid). On days E12 and E13 they were treated in the morning
witheither sterile or 20mg/kgMethotrexate(MTX)and1XFAor4XFA
and in the evening with either sterile or 1 X FA or 4 X FA resulting in 4
experimental groups. We observed spinal deformities in mice that
received higher dose of folinic acid. Defects observed included
improper neural tube closure at the cervical and/or lumbar region of
the spinal cord, improper fusion of the spine resulting inmajor defects.
Defects were also noted in the fore and hindbrain. This leads us back to
thekeyquestion Doyouneed the same level of folate at all timesduring
pregnancy? Or should folate levels be stage specific?
Funding: NEIU Committee on Research.
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Circadian oscillators are endogenous time-keeping mechanisms
that drive twenty four hour rhythmic changes in gene expression,
metabolism, hormone levels, and physical activity. We have character-
ized the developmental expression of genes known to regulate
circadian rhythms. Core circadian oscillator genes (xPeriod1 and 2,
xBmal1, xClock, xCryptochrome1, and 2) as well as genes acted upon by
the oscillator (outputs; xNocturnin and xNAT) are expressed in the
developing nervous system and eye. These genes were differentially
expressed in non-neural tissues such as the somites, heart, cement
gland, and pronephros. The ontogeny of circadian rhythm in the
embryonic eye was studied by isolating eyes at the appropriate
developmental age every 4h in a 12hour lightdark cycle. xBmal1
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